Skip to main content
Log in

Primary biliary cholangitis: review for radiologists

  • Special Section: Benign Biliary Disease
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Primary biliary cholangitis is a rare progressive chronic inflammation of the medium and small bile ducts that abdominal radiologists may encounter, particularly if working in a tertiary setting or at a transplant center. This brief review covers current thinking about the pathophysiology and presentation of the disease, as well as the current diagnostic criteria in use by hepatologists. Imaging strategies for diagnosis will be reviewed as well as current treatment strategies and the use of imaging in monitoring response to treatment, including image-guided elastography.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Beuers U, Boberg KM, Chapman RW, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237-67.

    Article  Google Scholar 

  2. Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from ’cirrhosis’ to ’cholangitis’. Hepatology 2015;62(5):1620–2.

    Article  Google Scholar 

  3. Lleo A, Colapietro F. Changes in the Epidemiology of Primary Biliary Cholangitis. Clin Liver Dis. 2018;22(3):429-41.

    Article  Google Scholar 

  4. Kita H, Matsumura S, He XS, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest. 2002;109(9):1231-40.

    Article  CAS  Google Scholar 

  5. Carrion AF, Rosen JD, Levy C. Understanding and Treating Pruritus in Primary Biliary Cholangitis. Clin Liver Dis. 2018;22(3):517-32.

    Article  Google Scholar 

  6. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50(1):291-308.

    Article  Google Scholar 

  7. Quarneti C, Muratori P, Lalanne C, Fabbri A, Menichella R, Granito A, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int 2015;35:636–641.

    Article  Google Scholar 

  8. Hirschfield GM, Beuers U, Corpechot C, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145-72.

    Article  Google Scholar 

  9. Tan D, Goodman ZD. Liver Biopsy in Primary Biliary Cholangitis: Indications and Interpretation. Clin Liver Dis. 2018;22(3):579-88.

    Article  Google Scholar 

  10. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978;379(2):103-12.

    Article  CAS  Google Scholar 

  11. Tanaka A, Leung PSC, Gershwin ME. The Genetics and Epigenetics of Primary Biliary Cholangitis. Clin Liver Dis. 2018;22(3):443-55.

    Article  Google Scholar 

  12. Tsianos EV, Hoofnagle JH, Fox PC, et al. Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology. 1990;11(5):730-4.

    Article  CAS  Google Scholar 

  13. Chalifoux SL, Konyn PG, Choi G, Saab S. Extrahepatic Manifestations of Primary Biliary Cholangitis. Gut Liver. 2017;11(6):771-80.

    Article  Google Scholar 

  14. Glass LM, Su GL. Metabolic Bone Disease in Primary Biliary Cirrhosis. Gastroenterol Clin North Am. 2016;45(2):333-43.

    Article  Google Scholar 

  15. Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69(1):394-419.

    Google Scholar 

  16. Kobayashi S, Matsui O, Gabata T, et al. MRI findings of primary biliary cirrhosis: correlation with Scheuer histologic staging. Abdom Imaging. 2005;30(1):71-6.

    Article  CAS  Google Scholar 

  17. Haliloglu N, Erden A, Erden I. Primary biliary cirrhosis: evaluation with T2-weighted MR imaging and MR cholangiopancreatography. Eur J Radiol. 2009;69(3):523-7.

    Article  Google Scholar 

  18. Kovač JD, Ješić R, Stanisavljević D, et al. Integrative role of MRI in the evaluation of primary biliary cirrhosis. Eur Radiol. 2012;22(3):688-94.

    Article  Google Scholar 

  19. Idilman IS, Venkatesh SH, Eaton JE, et al. Magnetic resonance imaging features in 283 patients with primary biliary cholangitis. Eur Radiol. 2020;30(9):5139-48.

    Article  CAS  Google Scholar 

  20. Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford). 2010;12(8):567-76.

    Article  Google Scholar 

  21. Han D, Liu J, Jin E, He W. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Jpn J Radiol. 2019;37(5):412-9.

    Article  CAS  Google Scholar 

  22. Takeyama Y, Tsuchiya N, Kunimoto H, et al. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis. Hepatol Res. 2015;45(10):E108-14.

    Article  CAS  Google Scholar 

  23. Wenzel JS, Donohoe A, Ford KL, Glastad K, Watkins D, Molmenti E. Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign. AJR Am J Roentgenol. 2001;176(4):885-9.

    Article  CAS  Google Scholar 

  24. Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol (NY). 2017;42(2):490-501.

    Article  Google Scholar 

  25. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273

    Article  CAS  Google Scholar 

  26. Blachar A, Federle MP, Brancatelli G (2001) Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220:329–336

    Article  CAS  Google Scholar 

  27. Corpechot C, Carrat F, Poujol-Robert A, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012;56(1):198-208.

    Article  Google Scholar 

  28. Zhang DK, Chen M, Liu Y, Wang RF, Liu LP, Li M. Acoustic radiation force impulse elastography for non-invasive assessment of disease stage in patients with primary biliary cirrhosis: A preliminary study. Clin Radiol. 2014;69(8):836-40.

    Article  Google Scholar 

  29. Goertz RS, GaBmann L, Strobel D, et al. Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases. Ann Hepatol. 2019;18(1):23-9.

    Article  Google Scholar 

  30. Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology. 2020;296(2):263-74.

    Article  Google Scholar 

  31. Guglielmo FF, Venkatesh SK, Mitchell DG. Liver MR Elastography Technique and Image Interpretation: Pearls and Pitfalls. Radiographics. 2019;39(7):1983-2002.

    Article  Google Scholar 

  32. Osman KT, Maselli DB, Idilman IS, et al. Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis. J Clin Gastroenterol. 2021;55(5):449-57.

    Article  CAS  Google Scholar 

  33. Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging. 2015;40(4):818-34.

    Article  Google Scholar 

  34. Kowdley KV. An Examination of the Evidence Behind Biochemical Markers in Primary Biliary Cholangitis. Gastroenterol Hepatol (N Y). 2021;17(5 Suppl 5):5-11.

    Google Scholar 

  35. Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28(2):296-301.

    Article  Google Scholar 

  36. Hyslop WB, Kierans AS, Leonardou P, et al. Overlap syndrome of autoimmune chronic liver diseases: MRI findings. J Magn Reson Imaging. 2010;31(2):383-9.

    Article  Google Scholar 

  37. Ringe KI, Bergquist A, Lenzen H, et al. Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC). Eur J Radiol. 2020;129:109101.

  38. Katabathina VS, Khalil S, Shin S, Lath N, Menias CO, Prasad SR. Immunoglobulin G4-Related Disease: Recent Advances in Pathogenesis and Imaging Findings. Radiol Clin North Am. 2016;54(3):535-51.

    Article  Google Scholar 

  39. Guidry C, Fricke RG, Ram R, Pandey T, Jambhekar K. Imaging of Sarcoidosis: A Contemporary Review. Radiol Clin North Am. 2016;54(3):519-34.

    Article  Google Scholar 

  40. Poupon R. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action. Clin Res Hepatol Gastroenterol 2012;36(Suppl 1):S3–12.

    Article  CAS  Google Scholar 

  41. Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106(5):1284–90.

    Article  CAS  Google Scholar 

  42. Poupon RE, Lindor KD, Pares A, et al. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003;39(1):12–6.

    Article  CAS  Google Scholar 

  43. FDA Drug Safety Communication, 05–26–2021 [Accessed October 16, 2021] Available at: https://www.fda.gov/media/149516/download

  44. Corpechot C, Chazouillères O, Rousseau A, et al. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N Engl J Med. 2018;378(23):2171-81.

    Article  CAS  Google Scholar 

  45. Locke GR 3rd, Therneau TM, Ludwig J, et al. Time course of histological progression in primary biliary cirrhosis. Hepatology 1996;23(1):52–6.

    Article  Google Scholar 

  46. Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20(6):707–13.

    Article  CAS  Google Scholar 

  47. Carbone M, Neuberger J. Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol. 2011;35(6-7):446-54.

    Article  Google Scholar 

  48. Assis DN. Chronic Complications of Cholestasis: Evaluation and Management. Clin Liver Dis. 2018;22(3):533-44.

    Article  Google Scholar 

Download references

Funding

No funding or research support for this article.

Author information

Authors and Affiliations

Authors

Contributions

Both authors made substantial contributions to the conception or design of the work; drafted the work or revised it critically for important intellectual content; approved the version to be published; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Matthew A. Morgan.

Ethics declarations

Conflict of interest

No conflict of interest or competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morgan, M.A., Sundaram, K.M. Primary biliary cholangitis: review for radiologists. Abdom Radiol 48, 127–135 (2023). https://doi.org/10.1007/s00261-021-03335-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-021-03335-x

Keywords

Navigation